Publications by authors named "Ruijiao Yuan"
Objective: The aim of this study was to identify the active components of Shengxian Decoction (SXT) and to elucidate the multi-component, multi-target, and multi-pathway regulatory mechanisms underlying the efficacy of SXT in treating lung adenocarcinoma (LUAD).
Methods: The effects of SXT extract on proliferation, migration, and invasion capabilities of human LUAD cells were determined through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), wound healing, and Transwell assays. High-Performance Liquid Chromatography (HPLC) was employed to pinpoint the primary active constituents of SXT.
Rationale: Pancreatic mixed serous neuroendocrine neoplasm (PMSNN) is an extremely rare disease. Only a few cases on the surgical treatment of PMSNN have been reported in the literature, and it is unclear whether there is invasion of important peripancreatic vessels.
Patient Concerns: We report the case of a 39-year-old female patient with PMSNN accompanied by invasion of important peripancreatic vessels.
Shengxian Decoction (SXT) is a traditional Chinese medicine prescription comprising several anti-cancer medicinal herbs. However, the anti-cancer effect of SXT has rarely been reported. Herein, we explored the therapeutic potential of SXT for the treatment of lung adenocarcinoma (LUAD).
View Article and Find Full Text PDFArticle Synopsis
- The global pandemic poses challenges for emergency surgeries in elderly patients with high-risk acute abdominal conditions like acute gangrenous cholecystitis.
- An 89-year-old male with multiple health issues underwent successful emergency laparoscopic cholecystectomy and recovered well despite the risks posed by his age and medical history.
- Successful emergency surgeries during the pandemic require strict adherence to hospital safety protocols and meticulous preparation and management throughout the process.